Arcturus Therapeutics
ARCT
ARCT
128 hedge funds and large institutions have $353M invested in Arcturus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 130 → 128 (-2)
39% less capital invested
Capital invested by funds: $578M → $353M (-$225M)
Holders
128
Holding in Top 10
1
Calls
$11.1M
Puts
$5.49M
Top Buyers
| 1 | +$7.68M | |
| 2 | +$3.28M | |
| 3 | +$3.22M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.01M |
| 5 |
Goldman Sachs
New York
|
+$1.39M |
Top Sellers
| 1 | -$6.47M | |
| 2 | -$3.16M | |
| 3 | -$2.6M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.75M |
| 5 |
Rafferty Asset Management
New York
|
-$1.61M |